Daxor EPS - Earnings per Share 2010-2011 | DXR
Daxor eps - earnings per share from 2010 to 2011. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Daxor Annual EPS | |
|---|---|
| 2011 | $-1.70 |
| 2010 | $1.17 |
| 2009 | $1.36 |
| Daxor Quarterly EPS | |
|---|---|
| 2011-12-31 | $-0.36 |
| 2011-09-30 | $-0.99 |
| 2011-06-30 | $-0.04 |
| 2011-03-31 | $-0.31 |
| 2010-12-31 | $0.53 |
| 2010-09-30 | $0.62 |
| 2010-06-30 | $0.04 |
| 2010-03-31 | $-0.02 |
| 2009-12-31 | $-0.36 |
| 2009-09-30 | $0.62 |
| 2009-06-30 | $1.46 |
| 2009-03-31 | $-0.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.053B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $20.312B | 19.41 |
| Encompass Health (EHC) | United States | $12.264B | 24.50 |
| DaVita (DVA) | United States | $9.850B | 14.09 |
| Elanco Animal Health (ELAN) | United States | $9.117B | 20.39 |
| Chemed (CHE) | United States | $6.673B | 22.35 |
| RadNet (RDNT) | United States | $5.520B | 199.33 |
| Option Care Health (OPCH) | United States | $4.655B | 19.92 |
| LifeStance Health (LFST) | United States | $2.131B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.123B | 22.85 |
| Astrana Health (ASTH) | United States | $1.792B | 62.67 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.671B | 30.77 |
| U.S Physical Therapy (USPH) | United States | $1.260B | 31.52 |
| Atai Life Sciences (ATAI) | Germany | $0.982B | 0.00 |
| Pennant (PNTG) | United States | $0.830B | 29.28 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.051B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |